Ruben Rathnasingham, PhD has more than 15 years of biomedical leadership experience in several companies founded on technologies invented and developed in academic institutions. In his current role, as the Assistant Dean for Health Product Innovation at the Dell Medical School, he is responsible for creating and growing initiatives to support health-related translational research at UT Austin. This includes leading the newly formed Texas Health Catalyst Program which brings product development and commercialization expertise from industry into the academic setting to maximize the health impact of academic research. Most recently, he was Associate Director of Early Translational Research at the University of California, San Francisco, where he helped develop and led the UCSF Catalyst Program which successfully leveraged industry partners to help identify, support and translate technologies through and out of the university. Prior to his tenure in academia, Ruben co-founded and grew a number of healthcare companies, including most recently, StrataGent Life Sciences, where he helped developed a needle free, wearable infusion pump that was honored with a 2010 Edison Award for Best New Product. Ruben has a Masters in Engineering from Imperial College, London University, and a MS and Ph.D. from MIT.